About
Biologics Discovery Technology
Areas of Focus
Categories
Biologics & BiopharmaceuticalJapan
Clinical Trials (6)
View allTotal Trials
6
As Lead Sponsor
6
As Collaborator
0
Total Enrollment
340
By Phase
PHASE1: 3PHASE2: 3
By Status
COMPLETED: 4TERMINATED: 2
Clinical Trials Pipeline6 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
Today
Hover over trial bars to see details
Recent Trials
NCT04863287Lead Sponsor
First Clinical Study of the Safety and Blood Levels of a Human Monoclonal Antibody (2217LS) Against Lyme Disease Bacteria in Healthy People
PHASE1Completed
44 participants
Started: Feb 11, 2021 · Completed: Aug 16, 2022
NCT04075175Lead Sponsor
Evaluate the Safety Pharmacokinetics of a Human Monoclonal Antibody S315 Against Diphtheria Toxin in Healthy Subjects
PHASE1Completed
41 participants
Started: Apr 23, 2019 · Completed: Oct 7, 2019
NCT01532908Lead Sponsor
Open Label Study of the Efficacy and Safety of MBL-HCV1 in Combination With Oral Direct-Acting Antivirals in Patients Undergoing Liver Transplantation for Hepatitis C
PHASE2Terminated
11 participants
Started: Nov 21, 2012 · Completed: Aug 27, 2015
NCT01121185Lead Sponsor
Study in Hepatitis C Virus (HCV) Infected Patients Undergoing Liver Transplantation to Evaluate a Human Monoclonal Antibody Against Hepatitis C
PHASE2Terminated
13 participants
Started: Jun 30, 2010 · Completed: Jun 30, 2011
NCT00952263Lead Sponsor
Study in Healthy Volunteers to Evaluate a Human Monoclonal Antibody Against Hepatitis C
PHASE1Completed
31 participants
Started: Jul 31, 2009 · Completed: Dec 31, 2009
Locations (1)
Headquarters
Tokyo, Japan
Map
Loading map...